Alembic Pharmaceuticals has informed the exchange that the company has received US Food & Drug Administration (USFDA) Final Approval for Formoterol Fumarate Inhalation Solution, 20 mcg/2 ml per Unit-Dose Vial. In this regard, the company has attached a press release on November 23rd, 2021.
The above information is a part of company’s filings submitted to BSE.